AXQ Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
AXQ Capital's VRTX Position: Q2 2026 in Review
AXQ Capital opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 2,797 shares worth $1.39M. The stake represents 0.15% of the portfolio and ranks #215 among its holdings. This is a return to the name: AXQ Capital previously reported a position in VRTX as recently as Q2 2025.
AXQ Capital first reported a position in VRTX in Q4 2023 and has held it in 4 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- AXQ Capital held 2,797 shares of Vertex Pharmaceuticals worth $1.39M as of Q2 2026.
- Vertex Pharmaceuticals was a new AXQ Capital position in Q2 2026.
- Vertex Pharmaceuticals made up 0.15% of AXQ Capital's portfolio in Q2 2026, its #215 holding.
- AXQ Capital first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 4 quarters since.
- 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.